In this study, we found that higher expression of CST1 is positively correlated with longer overall survival for breast cancer (BRCA) and bladder cancer (BLCA), while it is negatively correlated with overall survival for low‐grade glioma (LGG). The gene discussed is CST1; the disease is bladder transitional cell carcinoma.